Autor(es)

Azevedo, Lara Ferreira ; Karpova, Nina ; Rocha, Bruno Alves ; Barbosa Jr, Fernando ; Gobe, Glenda Carolyn ; Carneiro, Maria Fernanda Hornos

• Tipo de documento: Artigo Científico
• Fonte: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH; v. 20, n. 2, p. 19-pg., 2023-01-01.

Resumo

Although the molecular mechanisms underlying methylmercury toxicity are not entirely understood, the observed neurotoxicity in early-life is attributed to the covalent binding of methylmercury to sulfhydryl (thiol) groups of proteins and other molecules being able to affect protein post-translational modifications from numerous molecular pathways, such as glutamate signaling, heat-shock chaperones and the antioxidant glutaredoxin/glutathione system. However, for other organomercurials such as ethylmercury or thimerosal, there is not much information available. Therefore, this review critically discusses current knowledge about organomercurials neurotoxicity-both methylmercury and ethylmercury-following intrauterine and childhood exposure, as well as the prospects and future needs for research in this area. Contrasting with the amount of epidemiological evidence available for methylmercury, there are only a few in vivo studies reporting neurotoxic outcomes and mechanisms of toxicity for ethylmercury or thimerosal. There is also a lack of studies on mechanistic approaches to better investigate the pathways involved in the potential neurotoxicity caused by both organomercurials. More impactful follow-up studies, especially following intrauterine and childhood exposure to ethylmercury, are necessary. Childhood vaccination is critically important for controlling infectious diseases; however, the safety of mercury-containing thimerosal and, notably, its effectiveness as preservative in vaccines are still under debate regarding its potential dose-response effects to the central nervous system. (AU)

• Processo FAPESP: 16/10456-0 - Avaliação da expressão proteica e parâmetros bioquímicos relacionados com diabetes mellitus tipo II e dislipidemias em animais expostos aos contaminantes bisfenóis A e S
• Beneficiário: Lara Ferreira Azevedo
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
• Processo FAPESP: 18/24069-3 - Do biomonitoramento ao reconhecimento de assinaturas do exposoma humano visando antecipar riscos para uma saúde contínua
• Beneficiário: Fernando Barbosa Júnior
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 18/19554-0 - Avaliação dos mecanismos associados à desregulação da homeostase energética após exposição ao bisfenol A ou S através da metabolômica não dirigida
• Beneficiário: Lara Ferreira Azevedo
• Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Doutorado Direto
• Processo FAPESP: 16/07661-0 - Comparação dos efeitos tóxicos do bisfenol A e bisfenol S individualmente e associados em células HepG2
• Beneficiário: Maria Fernanda Hornos Carneiro
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 14/06744-4 - Avaliação do potencial terapêutico de nanopartículas de ouro ferromagnéticas em ratos com artrite reumatóide
• Beneficiário: Maria Fernanda Hornos Carneiro
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado